Видео ютуба по тегу Biologicdevelopment

Mass Spec Approaches to Supporting Biologic Development
Mass Spec Approaches to Supporting Biologic Development
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
De-risking Biologic Development: Engineering Flexibility from Early Development to Launch
Watch Webinar: Advanced Tools to Shorten Biologic Development Timelines
Watch Webinar: Advanced Tools to Shorten Biologic Development Timelines
Landscape of OA Drug and Biologic Development, CDER Regulatory Perspective | Robert Shibuya
Landscape of OA Drug and Biologic Development, CDER Regulatory Perspective | Robert Shibuya
Navigating FDA: Drug (and Biologic) Development Requirements
Navigating FDA: Drug (and Biologic) Development Requirements
Landscape of OA Drug and Biologic Development, CBER Regulatory Perspective | Elizabeth Hart
Landscape of OA Drug and Biologic Development, CBER Regulatory Perspective | Elizabeth Hart
Types of Drug & Biologic Submissions
Types of Drug & Biologic Submissions
💊 Journey of a Biologic Drug – From Lab to Market
💊 Journey of a Biologic Drug – From Lab to Market
BioPharma Summits - ADC Characterization on a Single Platform with Q Exactive BioPharma
BioPharma Summits - ADC Characterization on a Single Platform with Q Exactive BioPharma
Small Molecule vs Biologics
Small Molecule vs Biologics
CHO Cell Line Development — From DNA to IND Ready with Certainty
CHO Cell Line Development — From DNA to IND Ready with Certainty
Meet the Expert: James Valentine and Richard Lewis
Meet the Expert: James Valentine and Richard Lewis
Plant-Based Biologics With iBio's Randy Maddux
Plant-Based Biologics With iBio's Randy Maddux
Reshoring Biologics Development and Manufacturing for a Streamlined Path to IND
Reshoring Biologics Development and Manufacturing for a Streamlined Path to IND
Adolescent Growth and Development Milestones Nursing NCLEX Teen Review
Adolescent Growth and Development Milestones Nursing NCLEX Teen Review
The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
Importance of Regulatory Affairs in the Process of Drug Development: Clinreg Partners
Importance of Regulatory Affairs in the Process of Drug Development: Clinreg Partners
Catalent: An Innovative Approach
Catalent: An Innovative Approach
What does the Clin Pharm Plan for a Biologic Look Like?
What does the Clin Pharm Plan for a Biologic Look Like?
Catalent: Why Catalent
Catalent: Why Catalent